Samsung Biologics

SOUTH KOREA — In a strategic move to fortify its position as a leading global contract development and manufacturing organization (CDMO), Samsung Biologics has ushered…

SOUTH KOREA — In a remarkable show of strength, Samsung Biologics, a Contract Development and Manufacturing Organization (CD­MO), has reported a staggering 33% increase in…

SOUTH KOREA — In an exciting development for the biologics manufacturing sector, Samsung Biologics, based in South Korea, has announced a significant expansion of its…

UAE – Samsung Gulf Electronics (SGE) has partnered with a Dubai-based medical expert Dr. Sarah Gabriel Jabbour to improve the public health and wellbeing of…

SOUTH KOREA — Samsung Biologics, a leading contract-based drug manufacturer from South Korea, has recently announced the signing of two significant biosimilar product-manufacturing contracts with…

SOUTH KOREA — Samsung Biologics, a leading biopharmaceutical company based in South Korea, has secured a significant contract worth US$411 million from pharmaceutical giant Pfizer.…

SOUTH KOREA — Samsung Biologics, a CDMO, has announced that it will construct a fifth plant in response to growing market demand. The new facility,…

SOUTH KOREA — Samsung Biologics, a contract development and manufacturing organization (CDMO), has signed a biologics supply contract with pharma giant Pfizer worth KRW 241…

SOUTH KOREA – Samsung Biologics CEO John Rim has said the South Korean biotech will explore the possibility of adding cell and gene therapy to…